The biotech market offers great investment potential due to innovative advancements in genetic profiling, biologics, CRISPR ...

VACANCY: Medical Information Assistant For the past 20 years, ProPharma has improved the health and wellness of patients by ...

Intra-Cellular’s clinical-stage pipeline is promising, with pipeline agents under development for a wide range of neurological indications.

The macroenvironment in 2025 looks grim as signs of a slowdown in the economy set in. The biotech industry experienced a choppy ride in 2024, and the same is likely in store in 2025. Given the ...

Bayer AG plans to push pause on some of its pharmaceutical dealmaking, focusing instead on reducing the high debt load the ...

Samsung Group biotech unit is now Kospi's fourth-biggest company, outpacing world's largest CDMO, Lonza, in market cap ...

Pharma Sector Multibagger Opportunity - Explore how India could win big in the CDMO space with China-Plus-One strategy, ...

After selling its PI3Kα program to Eli Lilly, Scorpion will spinout out a different entity, which will be owned by the ...

It's JPM 2025 and here at Fierce Biotech we’re bringing you all the latest updates live from the life sciences event of the ...

Shin Yoo-yeol networks at JP Morgan conference as Lotte Biologics seeks contracts Shin Yoo-yeol makes inaugural appearance at ...

Trump administrations pro-corporation policies boost healthcare M&A prospects Healthcare investment outlook improves as Trump ...

From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech ...